Free. Unsubscribe any time.
Avidity Biosciences, Inc. (RNA)
Avidity Biosciences, Inc. filed 53 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 11 reporting owners, covering 78 transactions and 855,325 shares. None carries the SEC's AFF10B5ONE flag; all 53 name a plan in a footnote. 4 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-01-23, came on the same day as the one before it (2026-01-23) and reports 2 transactions against 2 in the filing before it.
- The sales it reports total 4,895 shares, 9,492 fewer than the 14,387 in the filing before it.
- Its 53 plan statements rank 98th of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 2 have more plan statements on file than it and 8 have fewer.
- Its 53 filings on file run from 2025-01-23 to 2026-01-23, and state 7 plan adoption dates, from 2024-06-12 to 2025-04-11.
Trades in Avidity Biosciences, Inc. 78
- Boyce Sarah — 2025-01-21 · S · 4,738 shares
- Boyce Sarah — 2025-01-21 · S · 5,659 shares
- Flanagan W. Michael — 2025-01-21 · S · 3,860 shares
- Flanagan W. Michael — 2025-01-21 · S · 1,812 shares
- Gallagher Kathleen P. — 2025-01-21 · S · 1,295 shares
- Gallagher Kathleen P. — 2025-01-21 · S · 670 shares
- Gallagher Kathleen P. — 2025-01-21 · S · 1,817 shares
- Hughes Steven George — 2025-01-21 · S · 1,915 shares
- Hughes Steven George — 2025-01-21 · S · 2,032 shares
- LEVIN ARTHUR A — 2025-01-21 · S · 1,872 shares
- MacLean Michael F — 2025-01-21 · S · 1,622 shares
- MacLean Michael F — 2025-01-21 · S · 1,665 shares
Adoption dates in Avidity Biosciences, Inc. 7
- 2024-06-12 — stated in 15 filings
- 2024-07-08 — stated in 1 filing
- 2024-08-15 — stated in 2 filings
- 2024-09-11 — stated in 3 filings
- 2024-10-17 — stated in 1 filing
- 2024-12-04 — stated in 2 filings
- 2025-04-11 — stated in 3 filings
Results prints in Avidity Biosciences, Inc. 4
- 2025-02-27
- 2025-05-08
- 2025-08-07
- 2025-11-10
Trades before a print in Avidity Biosciences, Inc. 16
- 1 day before the 2025-08-07 print — 2025-08-06 · S · Hughes Steven George · 11,283 shares
- 1 day before the 2025-08-07 print — 2025-08-06 · S · Hughes Steven George · 12,334 shares
- 1 day before the 2025-08-07 print — 2025-08-06 · S · Hughes Steven George · 6,167 shares
- 1 day before the 2025-08-07 print — 2025-08-06 · S · Hughes Steven George · 17,667 shares
- 1 day before the 2025-08-07 print — 2025-08-06 · S · Hughes Steven George · 33,983 shares
- 1 day before the 2025-08-07 print — 2025-08-06 · S · LEVIN ARTHUR A · 107,500 shares
- 1 day before the 2025-08-07 print — 2025-08-06 · S · MacLean Michael F · 30,914 shares
- 1 day before the 2025-08-07 print — 2025-08-06 · S · Mosbrooker Eric · 124,687 shares
- 1 day before the 2025-08-07 print — 2025-08-06 · S · Mosbrooker Eric · 6,120 shares
- 1 day before the 2025-08-07 print — 2025-08-06 · S · WILSON TROY EDWARD · 22,000 shares
- 1 day before the 2025-08-07 print — 2025-08-06 · S · WILSON TROY EDWARD · 7,500 shares
- 1 day before the 2025-08-07 print — 2025-08-06 · S · WILSON TROY EDWARD · 15,000 shares
Interval to Avidity Biosciences, Inc.’s next reported results date
How the interval and sources are counted →
- 16within 5 days
- 17within 10 days
- 1shortest, days
- 18no later print
- Gallagher Kathleen P. 2025-05-01 · S · 7 days before the 2025-05-08 print · Chief Program Officer
- Moriarty John B 2025-08-04 · S · 3 days before the 2025-08-07 print · Chief Legal Officer
- Hughes Steven George 2025-08-06 · S · 1 day before the 2025-08-07 print · Chief Medical Officer
- Hughes Steven George 2025-08-06 · S · 1 day before the 2025-08-07 print · Chief Medical Officer
- Hughes Steven George 2025-08-06 · S · 1 day before the 2025-08-07 print · Chief Medical Officer
- Hughes Steven George 2025-08-06 · S · 1 day before the 2025-08-07 print · Chief Medical Officer
- Hughes Steven George 2025-08-06 · S · 1 day before the 2025-08-07 print · Chief Medical Officer
- LEVIN ARTHUR A 2025-08-06 · S · 1 day before the 2025-08-07 print
- MacLean Michael F 2025-08-06 · S · 1 day before the 2025-08-07 print · Chief Financial Officer
- Mosbrooker Eric 2025-08-06 · S · 1 day before the 2025-08-07 print · Chief Commercial Officer
- Mosbrooker Eric 2025-08-06 · S · 1 day before the 2025-08-07 print · Chief Commercial Officer
- WILSON TROY EDWARD 2025-08-06 · S · 1 day before the 2025-08-07 print
- WILSON TROY EDWARD 2025-08-06 · S · 1 day before the 2025-08-07 print
- WILSON TROY EDWARD 2025-08-06 · S · 1 day before the 2025-08-07 print
- WILSON TROY EDWARD 2025-08-06 · S · 1 day before the 2025-08-07 print
- WILSON TROY EDWARD 2025-08-06 · S · 1 day before the 2025-08-07 print
- WILSON TROY EDWARD 2025-08-06 · S · 1 day before the 2025-08-07 print
Adoption dates Avidity Biosciences, Inc. states
- 2024-06-12 in 15 filings
- 2024-07-08 in 1 filing
- 2024-08-15 in 2 filings
- 2024-09-11 in 3 filings
- 2024-10-17 in 1 filing
- 2024-12-04 in 2 filings
- 2025-04-11 in 3 filings
Filing text: “10b5-1 trading plan previously adopted by the Reporting Person on June 12, 2024”
Reported results dates on file
- 2025-02-27
- 2025-05-08
- 2025-08-07
- 2025-11-10
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.